INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2020

Broccoli sprout capsules did not significantly alter 180-day survival in pancreatic cancer

Forty patients receiving palliative chemotherapy were placed unblinded into a treatment group (n = 29, receiving 15 daily capsules of pulverized broccoli sprouts) or placebo group (n = 11, receiving methylcellulose) for up to 1 year. The mean death rate was lower in the treatment group in the first 6 months (day 30: 0% vs 18%, day 90: 0% vs 25%, day 180: 25% vs 43%), but the endpoint at day 180 was not statistically significant (p = 0.291). Dropout rates after 1 year were high (72% treatment, 55% placebo). Taking 15 daily capsules was difficult for some patients, and the sprouts sometimes increased digestive problems, nausea, and emesis.

Study type
Unblinded controlled pilot trial
Who was studied
40 patients with advanced pancreatic cancer on palliative chemotherapy
What was measured
Patient characteristics, overall survival, and feasibility

THE PAPER

Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study.

Lozanovski VJ, Polychronidis G, Gross W, Gharabaghi N, Mehrabi A, Hackert T, Schemmer P, Herr I. Invest New Drugs, 2020.

PubMed 31250356 ↗DOI 10.1007/s10637-019-00826-z ↗

CancerTop 21: Broccoli

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.